Fact based stock research
ATEME (ENXTPA:ATEME)

FR0011992700

ATEME stock research in summary

ateme.com


ATEME shares are more expensive than other comparable stocks. They are riskily financed, show below average growth, and are poor value. We recommend evaluating whether the future of the company ATEME is really as positive as the high price of the shares suggests. If you come to the conclusion that the future for this company is only average, that could be a reason to sell this share.


Latest Obermatt Ranks


Country France
Industry Communications Equipment
Index CAC All
Size class X-Small

June 2, 2022. Stock data may be delayed. Login to get the most recent research.

Stock analysis by the purely financial fact-based Obermatt Method for the investment strategies Value, Growth and Safety for ATEME from June 2, 2022.

We invest in our stock tips ourselves and openly publish the returns of our portfolio. That's how much we believe in our stock research. Subscribe to the top 10 stocks for 100 markets conveniently by e-mail.